Erythropoietin to help clear lung fluid in ARDS
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests whether erythropoietin (EPO), a medicine that affects red blood cell production, can help clear extra fluid from the lungs in people with acute respiratory distress syndrome (ARDS). If it works, it could improve breathing and reduce lung fluid buildup during critical illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have sepsis that meets Sepsis-3 diagnostic criteria
- Be on a breathing machine (intubated mechanical ventilation)
- Have ARDS that meets the Berlin diagnostic criteria
- Be able and willing to sign informed consent and follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial studies an “extracellular vesicle” treatment in people with moderate to severe ARDS, a serious lung breathing problem. The goal is to see whether the treatment can improve outcomes compared with standard care.
This trial tests a new drug called LEAF-4L6715 to see if it helps people with severe acute respiratory distress syndrome (ARDS), a serious lung condition. If you are on a breathing machine and meet the criteria below, you may be able to join.
This trial tests whether umbilical cord stem cells are safe for people with mild to moderate ARDS. It aims to see if these cells can help reduce lung inflammation and improve breathing.
This trial tests whether an injection of stem cells from umbilical cords can help people with severe ARDS (a type of lung failure) recover faster. It is for those who have not improved after standard treatment and whose ARDS is caused by an infection (not COVID-19).
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This trial tests whether human umbilical cord mesenchymal stem cells given through an IV can help people with severe ARDS. It aims to see if the treatment is safe and if it can improve breathing and recovery.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.